Clinical trials
Urinary Bladder Neoplasms trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
81 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 3 |
| 2002 | 2 |
| 2005 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 3 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 9 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 6 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 7 |
| 2024 | 5 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 42 |
| Recruiting | 20 |
| Terminated | 9 |
| Active, not recruiting | 8 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 8 |
| Merck Sharp & Dohme LLC | 6 |
| Bristol-Myers Squibb | 5 |
| Hoffmann-La Roche | 5 |
| The Netherlands Cancer Institute | 5 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 4 |
| AstraZeneca | 4 |
| Eli Lilly and Company | 3 |
| Janssen Research & Development, LLC | 3 |
| Daiichi Sankyo | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 81 |
| Carcinoma, Transitional Cell | 15 |
| Lung Neoplasms | 10 |
| Neoplasms | 10 |
| Breast Neoplasms | 7 |
| Prostatic Neoplasms | 7 |
| Urethral Neoplasms | 7 |
| Head and Neck Neoplasms | 6 |
| Ovarian Neoplasms | 6 |
| Stomach Neoplasms | 6 |
Trials
Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.